GAUDIUMIVF
1 call
Concalls & earnings callsGaudium IVF and Women Health Limited
Every summarised call, newest first. Latest is Q1 FY27, held 14 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →Gaudium IVF's Q1 focused on investing ahead of its expansion roadmap, absorbing higher costs for marketing its new AI tools and new hub development while maintaining confidence in achieving its full-year growth targets.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Revenue from Operations (Q1 FY27) | ₹19.4 Cr | 9.1% | |
| EBITDA | ₹2.4 Cr | -52.96% | |
| EBITDA Margin | 12.5% | -1,651 bps | |
| PAT | ₹1.8 Cr | -42.27% |
Latest guidance
- Guidance of 30% revenue growth year-on-year for FY27.
- Confident in sustaining EBITDA and PAT margins for FY27.
Said on the Q1 FY27 call.
Call history
- Q1 FY27Positive tone
Gaudium IVF's Q1 focused on investing ahead of its expansion roadmap, absorbing higher costs for marketing its new AI tools and new hub development while maintaining confidence in achieving its full-year growth targets.
- Revenue from Operations (Q1 FY27)
- ₹19.4 Cr9.1%
- EBITDA
- ₹2.4 Cr-52.96%